How many insider declarations has Ahlers James M filed?

Ahlers James M has filed 1 public insider declaration with SEC (Form 4).

What is Ahlers James M's role?

Ahlers James M's reported role is not specified by the regulator across the filings.

Which companies does Ahlers James M report trades for?

Ahlers James M reports trades for Cue Biopharma, Inc..

← Executives ★ Sign in to follow

AJ

Ahlers James M

·SEC (Form 4)

Cue Biopharma, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Ahlers James M. Insider active across 1 company, notably Cue Biopharma, Inc.. Aggregated, 1 filings have been logged. History available since 30 July 2026. The latest transaction was disclosed on 30 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Ahlers James M

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cue Biopharma, Inc. (US)

Declarations1 total

◆

Ahlers James M

Chief Financial OfficerExecutives30 Jul 2026Cue Biopharma, Inc.

0SEC ↗

25,500 shares0Common StockSEC:0001320383-26-000006:0

1 of 1 declaration

InsidersTradesSigma

← Executives ★ Sign in to follow

AJ

Ahlers James M

·SEC (Form 4)

Cue Biopharma, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Ahlers James M. Insider active across 1 company, notably Cue Biopharma, Inc.. Aggregated, 1 filings have been logged. History available since 30 July 2026. The latest transaction was disclosed on 30 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.